Potentiating cancer vaccine efficacy in liver cancer

Hepatocellular carcinoma (HCC) is the most common liver malignancy with a poor prognosis and an overall 5-year survival rate of approximately 5–6%. This is due because standard of care treatment options are limited and none of them shows a sufficient efficacy. HCC is an “inflammation-induced cancer”...

Full description

Saved in:
Bibliographic Details
Published in:Oncoimmunology
Main Authors: Tagliamonte, Maria, Petrizzo, Annacarmen, Mauriello, Angela, Tornesello, Maria Lina, Buonaguro, Franco M, Buonaguro, Luigi
Format: Artigo
Language:Inglês
Published: Taylor & Francis 2018
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6169594/
https://ncbi.nlm.nih.gov/pubmed/30288355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1488564
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items